Anti-botulism antibody coformulations
US8821879B2 · kind B2 · utility
18Cited by
3References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2010 |
| Grant date | Sep 2, 2014 |
| Priority date | — |
| Expiry date | Dec 18, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to stable formulations of multiple antibodies comprising a plurality of anti-botulism antibodies and an effective amount of a succinate buffer, an effective amount of arginine, wherein the antibodies are present in substantially equal concentrations and the pH of the formulation is between about 5 and about 6.5.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.